Pooling of samples in proteomics experiments might help overcome resource constraints when many individuals are analysed. The measured biological variation should be reduced giving increased power to detect treatment differences. Pooling has been advocated in microarray work but there are few tests of its potential in proteomics. In this study, we examine three issues on which the success of the pooling approach might hinge and provide evidence that: (i) the protein expression in a pool matches the mean expression of the individuals making up the pool for the majority of proteins, although for some proteins the pool expression is different; (ii) the biological variance between pools is reduced compared with that between individuals, as predicted in theory, but this reduction is not as large as expected. A practical consequence of this is that power could be reduced; (iii) proteins detectable in individual samples are usually but not always visible when samples are pooled. We conclude that pooling of samples in proteomics work is a valid and potentially valuable procedure but consideration should be given to these issues in experimental design.
The study of the proteome (proteomics), which includes the dynamics of protein expression, regulation, interactions and its function, has played a less prominent role in evolutionary and ecological investigations in comparison with the study of the genome and transcriptome. There are, however, a number of arguments suggesting that this situation should change. First, the proteome is closer to the phenotype than the genome or the transcriptome, and as such may be more directly responsive to natural selection, and thus closely linked to adaptation. Second, there is evidence of a low correlation between protein and transcript expression levels across genes in many different organisms. Finally, there have been some recent important technological improvements in proteomics methods that make them feasible, practical and useful to address a wide range of evolutionary questions even in nonmodel organisms. The different proteomic methods, their limitations and problems when interpreting empirical data are described and discussed. In addition, the proteomic literature pertaining to evolutionary ecology is reviewed with examples, and potential applications of proteomics in a variety of evolutionary contexts are outlined. New proteomic research trends such as the study of posttranslational modifications and protein-protein interactions, as well as the combined use of the different -omics approaches, are discussed in relation to the development of a more functional and integrated perspective, needed for achieving a more comprehensive knowledge of evolutionary change.
In quantitative proteomics work, the differences in expression of many separate proteins are routinely examined to test for significant differences between treatments. This leads to the multiple hypothesis testing problem: when many separate tests are performed many will be significant by chance and be false positive results. Statistical methods such as the false discovery rate method that deal with this problem have been disseminated for more than one decade. However a survey of proteomics journals shows that such tests are not widely implemented in one commonly used technique, quantitative proteomics using two-dimensional electrophoresis. We outline a selection of multiple hypothesis testing methods, including some that are well known and some lesser known, and present a simple With the advent of high throughput genomics approaches, researchers need appropriate bioinformatic and statistical tools to deal with the large amounts of data generated. In quantitative proteomics work, differences in expression of many individual proteins between treatments or samples might need to be tested. Researchers must then address what has come to be known as the multiple hypothesis testing problem. Suppose 500 features such as protein spots in a two-dimensional electrophoresis (2-DE) 1 experiment, or mass spectrum features relating to protein or peptide abundance, are each compared between treatments using a t test. If the conventional a priori significance level of ␣ ϭ 0.05 is used, then 5% or about 25 significant features are expected to occur just by chance even if the null hypothesis of no treatment effect is true for all 500 features. Thus it is easier to make a false positive error when picking out significant results in an experiment with multiple features, than when considering one feature in isolation.A variety of statistical methods have been devised to deal with the multiple hypothesis testing problem. These are applicable in quantitative proteomics. In this paper we use examples from 2-DE proteomics to demonstrate these methods. In this technique, the intensity of signal from protein spots on 2-DE gels is measured and compared between gels. Use of the word "spot" is obviously not synonymous with use of the word "protein" in that it does not encompass all forms of a given protein such as alternatively spliced variants and posttranslational modification variants that might form spots in different positions on the gel. The multiple testing approach is introduced with the following example. Table I shows simulated data for a model of a 2-DE proteomics experiment in which 500 spots have been compared between two treatments using the t test. The third column gives p values significant at ␣ ϭ 0.05 sorted from low to high. A threshold line is shown drawn under spot 70. This has been selected arbitrarily for illustration of some properties of a threshold. The p values for the spots above the threshold are all less than ␣ ϭ 0.05 but we cannot declare them to be significant at the ␣ ϭ 0.05 level because of the multiple hypot...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.